stockrowCharles River Laboratories International, Inc. (CRL) vs Guardant Health, Inc. (GH)
- Charles River Laboratories International, Inc. CRL 327.56 +4.65%
- Guardant Health, Inc. GH 144.36 −5.91%
Charles River Laboratories International, Inc. and Guardant Health, Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $20.6B against $14.9B — 1.4× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Charles River Laboratories International, Inc. trades at 300×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against −1.16%. Charles River Laboratories International, Inc. has the higher net margin (1.01% vs −37.9%) and the higher return on invested capital (1.81% vs −25.7%). Across the 17 metrics below, Charles River Laboratories International, Inc. leads on 9 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | CRL | GH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.33% | 65.19% | 48.32% |
| Operating margin | 4.00% | (39.41%) | (5.68%) |
| Net margin | 1.01% | (37.93%) | (4.10%) |
| Free cash flow margin | 10.05% | (18.15%) | 0.00% |
| Return on equity | 1.21% | 153.90% | 0.00% |
| Return on assets | 0.54% | (30.68%) | (6.05%) |
| Return on invested capital | 1.81% | (25.68%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack